DrugPatentWatch Database Preview
Guselkumab - Biologic Drug Details
» See Plans and Pricing
Summary for guselkumab
| Tradenames: | 1 |
| Patents: | 2 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for guselkumab |
Recent Clinical Trials for guselkumab
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Centre for Human Drug Research, Netherlands | N/A |
| Janssen Pharmaceuticals | N/A |
| ZonMw: The Netherlands Organisation for Health Research and Development | Phase 4 |
Patent Text Search: US Patents for guselkumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Biotech | TREMFYA | guselkumab | INJECTABLE;INJECTION | 761061 | 001 | 2019-01-29 | Start Trial | UBE INDUSTRIES, LTD. (Yamaguchi, JP) | 2036-04-28 | RX | search | |
| Janssen Biotech | TREMFYA | guselkumab | INJECTABLE;INJECTION | 761061 | 001 | 2019-01-29 | Start Trial | The Regents of the University of California (Oakland, CA) | 2035-02-24 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for guselkumab
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | 112017017884 | Start Trial |
| Hong Kong | 1255666 | Start Trial |
| Mexico | 2017010721 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2016138034 | Start Trial |
| Japan | 2018506293 | Start Trial |
| Australia | 2016222887 | Start Trial |
| European Patent Office | 3262166 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
